SCHEMBL5556541

SCHEMBL5556541

CN1CCN(c2ccc(C(Br)C=O)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
MAPT P10636 4/20 0.49
KDM4E B2RXH2 2/20 0.49
GAA P10253 2/20 0.49
PTK2B Q14289 2/20 0.49
ADRA2C P18825 1/20 0.49
GFER P55789 1/20 0.49
KMT2A Q03164 1/20 0.49
ESR2 Q92731 1/20 0.49
SIRT6 Q8N6T7 1/20 0.46
LMNA P02545 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
CHKA P35790 1/20 0.41
HTR3A P46098 1/20 0.40
HDAC3 O15379 2/20 0.40
HDAC8 Q9BY41 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1506928 0.84 TRIM24 (0.53) ALDH1A1MAPTKDM4EGAAPTK2B
SCHEMBL6987741 0.83 ALDH1A1 (0.55) ALDH1A1MAPTKDM4EGAAGFER
SCHEMBL27741268 0.81 ALDH1A1 (0.59) ALDH1A1MAPTKDM4EGAAPTK2B
SCHEMBL21495008 0.81 PIK3CD (0.46) ALDH1A1MAPTKDM4EGAAKMT2A
SCHEMBL3234322 0.81 PIK3CD (0.46) ALDH1A1MAPTKDM4EGAAKMT2A
SCHEMBL14058868 0.80 ADRB1 (0.49) ALDH1A1KDM4ESIRT6LMNATP53
SCHEMBL6118334 0.77 ALDH1A1 (0.46) ALDH1A1KDM4EKMT2ARAB9ASMN1; SMN2
SCHEMBL4174461 0.76 ALDH1A1 (0.53) ALDH1A1MAPTKDM4EGAAPTK2B
SCHEMBL14058852 0.76 LMNA (0.53) ALDH1A1KDM4ELMNANPC1RAB9A
SCHEMBL14058888 0.75 DRD4 (0.60) ALDH1A1GAASIGMAR1HDAC3HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628666-A4 COMPOUDS AND USES THEREOF IN MODULATING AMYLOID BETA TORREYPINES THERAPEUTICS INC (US) 2007-12-05 EP disclosed
EP-1628666-A2 COMPOUDS AND USES THEREOF IN MODULATING AMYLOID BETA Torreypines Therapeutics, Inc. (US) 2006-03-01 EP disclosed
WO-2004110350-A2 COMPOUDS AND USES THEREOF IN MODULATING AMYLOID BETA TORREYPINES THERAPEUTICS, INC. (US) 2004-12-23 WO disclosed